Exec Chat: Abionic Is Accelerating Diagnostics To Save Lives
Executive Summary
Abionic CEO Nicolas Durand explains how Abionic is filling unmet needs in diagnostics and the Swiss company’s plans for expansion.
You may also be interested in...
LumiraDX Goes Public In SPAC Merger
Investors have been wary of LuminaraDX since its placement on NASDAQ, driving the share price down.
J&J Refines Direction For Ottava
Delays have plagued J&J's soft tissue surgical robot. However, the company has now solidified at least its near-term plan and hopes to commence trials later this year.
J&J Refines Direction For Ottava
Delays have plagued J&J's soft tissue surgical robot. However, the company has now solidified at least its near-term plan and hopes to commence trials later this year.